LysoPC(20:3(5Z,8Z,11Z))(1199257-41-4)
- Name: LysoPC(20:3(5Z,8Z,11Z))
- Synonyms:LysoPC(20:3(5Z,8Z,11Z));1-meadoyl-glycero-3-phosphocholine;1-meadoyl-sn-glycero-3-phosphocholine;LysoPC(20:3(5Z,8Z,11Z)/0:0);1199257-41-4;(2-{[(2R)-2-hydroxy-3-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium;(R)-2-Hydroxy-3-((5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate;CHEBI:74343;LysoPC(20:3n9/0:0);LysoPC(20:3w9/0:0);DTXSID301101927;LyPC(20:3n9/0:0);LyPC(20:3w9/0:0);LMGP01050139;LPC(20:3n9/0:0);LPC(20:3w9/0:0);Lysophosphatidylcholine(20:3n9/0:0);Lysophosphatidylcholine(20:3w9/0:0);HY-113029;CS-0059387;LysoPC 20:3(5Z,8Z,11Z)/0:0;LPC 20:3(5Z,8Z,11Z)/0:0;LPC(20:3(5Z,8Z,11Z)/0:0);lysophosphatidylcholine(20:3(5Z,8Z,11Z)/0:0);PC 20:3(5Z,8Z,11Z)/0:0;PC(20:3(5Z,8Z,11Z)/0:0);Q27144624;(2R)-2-hydroxy-3-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]propyl 2-(trimethylammonio)ethyl phosphate;3,5,9-Trioxa-4-phosphanonacosa-14,17,20-trien-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (7R,14Z,17Z,20Z)-
- Molecular Formula:C28H52NO7P
- Molecular Weight:545.7
- CAS Registry Number:1199257-41-4
- EINECS:
- Melting Point:
- Water Solubility:

Other Product
- 749927-85-3/1-(4-Iodo-3,5-dimethyl-1H-pyrazol-1-yl)ethanone
- 764646-19-7/N~2~-(4-Methoxyphenyl)-N~6~-[4-(propan-2-yl)phenyl]-7H-purine-2,6-diamine
- 765937-96-0/N~2~-(tert-Butoxycarbonyl)-2-(difluoromethyl)-L-ornithine
- 773873-07-7/2-Bromo-6-(hydroxymethyl)-4-(trifluoromethyl)phenol
- 1338535-94-6/Thieno[2,3-c]quinolin-4(5H)-one, 8-[(3S)-3-amino-1-pyrrolidinyl]-2-(4-hydroxyphenyl)-
- 457939-77-4/S46M7A5CM8
- 1314961-49-3/1H-2-Benzopyran-1-one, 7-methyl-3-(1-naphthalenyl)-
- 1445876-91-4/2-(5-Hydroxypentyl)-2-methylpropanedioic acid
- 1343474-22-5/Nimorazole maleate
- 861238-36-0/(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-14-hydroxy-3-(3-methyl-1-oxobutoxy)morphinan-6-one
- 1303607-61-5/(2'S,3R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-7-fluoro-1,2-dihydro-N-(cis-3-hydroxy-3-methylcyclobutyl)-2-oxospiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide
- 1447998-30-2/Oxybutynin xinafoate
- 90214-81-6/alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-O(CH2)2S(CH2)2CO2Me
- 87019-30-5/alpha-D-Galp-(1->4)-beta-D-Galp-O(CH2)2S(CH2)2CO2Me
- 125636-92-2/4beta-Hydroxystanozolol
- 1514924-89-0/4b-OH-stanozolol
- 106182-29-0/Heptadecanoyl carnitine
- 77715-45-8/Cholesteryl eicosadienoate
- 56162-46-0/Cortolone-3-glucuronide
- 1199257-41-4/LysoPC(20:3(5Z,8Z,11Z))
- 899443-67-5/LysoPE(0:0/18:0)
- 869485-73-4/MG(20:3(8Z,11Z,14Z)/0:0/0:0)
- 1044598-64-2/MG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0/0:0)
- 125650-87-5/LacCer(d18:1/20:0)
- 105087-85-2/N-(tetracosanoyl)-1-b-lactosyl-sphing-4-enine
- 204120-61-6/S-(4,8-dimethylnonanoate
- 497258-54-5/5-Taurinomethyl-2-thiouridine
- 169523-06-2/(2R)-3-sulfanyl-2-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenamido]propanoic acid
- 852100-88-0/3-O-Sulfogalactosylceramide (d18:1/12:0)
- 928346-40-1/3-O-Sulfogalactosylceramide (d18:1/26:1(17Z))